Preliminary Program - May be subject to change.

Friday, March 6, 2009

5:00 pm - 9:00 pm            Registration, Exhibits and Reception - Hidalgo B

6:00 pm - 8:00 pm            Nurses’ Session - Hidalgo A

6:00 pm - 6:45 pm            Nursing Implications of New Agents

                                             Susan Smith, MSN

6:45 pm - 7:00 pm            Questions

7:00 pm - 7:45 pm            Regulatory Implications of Testing New Agents

                                             Stacey Young-McCaughan, RN, PhD, AOCN

7:45 pm - 8:00 pm            Questions

Saturday, March 7, 2009

7:00 am - 8:00 am            Registration and Continental Breakfast

8:00 am - 8:05 am            Welcome and Overview of the Conference

                                             Francis Giles, MB, MD, FRCPI, FRCPath

 8:05 am - 8:50 am           What are the new agents and how do they work?

                  Alain Mita, MD

8:50 am - 9:00 am            Questions

9:00 am - 9:35 am            Practical Applications of New Drugs in Breast Cancer

                                             Edgardo Rivera, MD

9:35 am - 9:50 am            Questions

9:50 am - 10:00 am          Break

10:00 am - 10:35 am        Practical applications of new agents in hematological

                                              malignancies

                                              Francis Giles, MB, MD, FRCPI, FRCPath

10:35 am - 10:50 am        Questions

10:50 am - 11:10 am        mTOR Pathway, mTOR Inhibitors in Development: Practical

                                              Aspects

                                              Monica Mita, MD

11:10 am - 11:20 am        Questions

11:20 am - 11:55 am        Practical Applications of New Drugs in Lung Cancer

                                              Alan Sandler, MD

11:55 am - 12:10 pm        Questions

12:10 pm - 1:15 pm          Lunch (provided)

 1:15 pm - 1:35 pm           Targeting the IGFR Pathway: Drugs in Development and Practical

                                             Aspects  (working title)

                  Swaminathan Padmanabhan, MD

1:35 pm - 1:50 pm            Questions

1:50 pm - 2:25 pm           The Shepherd and the Lamb – A Patient’s 6th Vital Sign

                                             Daniel Von Hoff, MD, FACP

2:25 pm - 2:40 pm            Questions

2:40 pm - 3:15 pm            Practical Applications of New Agents in Renal Cell Carcinoma

                                             Robert Figlin, MD, FACP

3:15 pm - 3:30 pm            Questions

3:30 pm - 3:45 pm            Break

3:45 pm - 5:00 pm            Meet the Expert Sessions

5:00 pm - 5:30 pm            Evaluation and Post-test

5:30 pm                              Adjournment